NanosanguisS.A.Status: Entity active

Nanosanguis is a biotechnology company focused on utilizing nanotechnology in medicine, specifically in the fields of transplantation and transfusion. It aims to increase the availability of organs for transplantation by developing innovative organ perfusion systems and a safe, effective blood substitute. The company also seeks to enhance organ preservation methods and expand the donor pool by utilizing kidneys from donors after circulatory death.